QuidelOrtho Corporation , a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced that members.
QuidelOrtho Reports First Quarter 2024 Financial Results marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
The Board of Directors has terminated President and Chief Executive Officer, Douglas Bryant and appointed, on an interim basis, Michael Iskra as Chief Executive Officer and Robert Bujarski as.
QuidelOrtho Corporation , a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will.
Earlier-than-expected demand for respiratory products in core markets drives strong preliminary performance
Company to report third quarter 2023 financial results on November 1, 2023
.